Skip to main content

Table 2 Activities of the new mutants obtained by single or multiple combinations of aminoacid substitutions

From: New active site oriented glyoxyl-agarose derivatives of Escherichia colipenicillin G acylase

N. of Lys introduced

Mutants

Expression of the 95 kDa pre-pro-enzyme

Enzyme processinga

U(NIPAB)/mlb

U(NIPAB)/mg

0

Wt

+

+

25.0

5.0

1

αE194K

+

+

23.2

5.3

 

βD494K

+

+

27.0

5.4

 

βD403K

+

+

13.9

4.6

 

βR495K

+

-

n.d.c

n.d.c

 

βD216K

+

-

n.d.c

n.d.c

2

αE194K, βD494K

+

+

20.0

4.0

 

βD216K, βG219K

+

-

n.d.c

n.d.c

 

αN202K, αN205K

-

-

n.d.c

n.d.c

3

βD13K, βE272K, βR276K (3K)

+

+

19.0

4.3

4

(3K)+ βD494K

+

-

n.d.c

n.dc.

 

(3K)+ βR495K

+

-

n.d.c

n.d.c

5

3K+ βD216K+βG219K

+

-

n.d.c

n.d.c

  1. aEnzyme processing means presence of the two 65 and 24 kDa subunits in the SDS-PAGE analysis of periplasmic extract.
  2. bU, units are μmol of NIPAB hydrolyzed min-1 ml-1 of periplasmic extract.
  3. cn.d., means not detectable enzyme activity.